Lithium succinate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Headbomb (talk | contribs) at 15:18, 24 April 2019 (Alter: journal. | You can use this tool yourself. Report bugs here.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Lithium succinate
Clinical data
AHFS/Drugs.comMonograph
ATC code
Identifiers
  • lithium butanedioic acid
PubChem CID
ChemSpider
ECHA InfoCard100.163.153 Edit this at Wikidata
Chemical and physical data
FormulaC4H5LiO4
Molar mass124.02 g/mol g·mol−1
3D model (JSmol)
  • [Li+].[Li+].[O-]C(=O)CCC([O-])=O
  • InChI=1S/C4H6O4.2Li/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2 checkY
  • Key:WAHQBNXSPALNEA-UHFFFAOYSA-L checkY
  (verify)

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]

References

  1. ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology. 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
  2. ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International Journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500.